Erin McFadden

Soluble AXL as a marker of disease progression and survival in melanoma

Karine Flem‐Karlsen, Marta Nyakas, Inger Nina Farstad et al. · PLoS ONE · 2020 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

Retrospective Review of Predisposing Factors and Surgical Outcomes in Obstetric Fistula Patients at a Single Teaching Hospital in Western Kenya

Erin McFadden, Sarah Jane Taleski, Alan Bocking et al. · Journal of Obstetrics and Gynaecology Canada · 2011 · 40 citations

Medicine, Obstetrics, Surgery +14

Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma

Karine Flem‐Karlsen, Erin McFadden, Nasrin Omar et al. · Molecular Cancer Therapeutics · 2019 · 26 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Different Sensitivity of Advanced Bronchial and Alveolar Mono- and Coculture Models for Hazard Assessment of Nanomaterials

Elisabeth Elje, Espen Mariussen, Erin McFadden et al. · Nanomaterials · 2023 · 13 citations · Full text

Life Sciences, Cell Biology, Toxicology +17

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases

Viví Ann Flørenes, Karine Flem‐Karlsen, Erin McFadden et al. · Translational Oncology · 2019 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17